Novartis

D

Quotes are delayed by 15 minutes

Novartis P/E ratioWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.

Novartis's P/E ratio is 30.56: its share price of 160.42 over its earnings per share of 5.25 over the last twelve months.

Today

30.56

Forward P/E, next 12 months

16.46

PEG ratio

2.46

Median, 5 years

17.94

Low, 5 years

6.86

High, 5 years

31.43

P/E ratio = price ÷ EPS (last 12 months) = 160.42 ÷ 5.25 = 30.56

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Novartis's P/E ratio